Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,611 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Age-specific prevalence of dengue antibodies in Bangkok infants and children.
Pengsaa K, Limkittikul K, Luxemburger C, Yoksan S, Chambonneau L, Ariyasriwatana C, Lapphra K, Chanthavanich P, Lang J, Sabchareon A. Pengsaa K, et al. Among authors: lang j. Pediatr Infect Dis J. 2008 May;27(5):461-3. doi: 10.1097/INF.0b013e3181646d45. Pediatr Infect Dis J. 2008. PMID: 18360303
Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai children.
Sabchareon A, Lang J, Chanthavanich P, Yoksan S, Forrat R, Attanath P, Sirivichayakul C, Pengsaa K, Pojjaroen-Anant C, Chambonneau L, Saluzzo JF, Bhamarapravati N. Sabchareon A, et al. Among authors: lang j. Pediatr Infect Dis J. 2004 Feb;23(2):99-109. doi: 10.1097/01.inf.0000109289.55856.27. Pediatr Infect Dis J. 2004. PMID: 14872173 Clinical Trial.
Safety and immunogenicity of tetravalent live-attenuated dengue vaccines in Thai adult volunteers: role of serotype concentration, ratio, and multiple doses.
Sabchareon A, Lang J, Chanthavanich P, Yoksan S, Forrat R, Attanath P, Sirivichayakul C, Pengsaa K, Pojjaroen-Anant C, Chokejindachai W, Jagsudee A, Saluzzo JF, Bhamarapravati N. Sabchareon A, et al. Among authors: lang j. Am J Trop Med Hyg. 2002 Mar;66(3):264-72. doi: 10.4269/ajtmh.2002.66.264. Am J Trop Med Hyg. 2002. PMID: 12139219 Clinical Trial.
Decay and persistence of maternal dengue antibodies among infants in Bangkok.
van Panhuis WG, Luxemburger C, Pengsaa K, Limkittikul K, Sabchareon A, Lang J, Durbin AP, Cummings DA. van Panhuis WG, et al. Among authors: lang j. Am J Trop Med Hyg. 2011 Aug;85(2):355-62. doi: 10.4269/ajtmh.2011.11-0125. Am J Trop Med Hyg. 2011. PMID: 21813859 Free PMC article.
Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial.
Sabchareon A, Wallace D, Sirivichayakul C, Limkittikul K, Chanthavanich P, Suvannadabba S, Jiwariyavej V, Dulyachai W, Pengsaa K, Wartel TA, Moureau A, Saville M, Bouckenooghe A, Viviani S, Tornieporth NG, Lang J. Sabchareon A, et al. Among authors: lang j. Lancet. 2012 Nov 3;380(9853):1559-67. doi: 10.1016/S0140-6736(12)61428-7. Epub 2012 Sep 11. Lancet. 2012. PMID: 22975340 Clinical Trial.
Persistence of antibodies in children after intradermal or intramuscular administration of preexposure primary and booster immunizations with purified Vero cell rabies vaccine.
Sabchareon A, Chantavanich P, Pasuralertsakul S, Pojjaroen-Anant C, Prarinyanupharb V, Attanath P, Singhasivanon V, Buppodom W, Lang J. Sabchareon A, et al. Among authors: lang j. Pediatr Infect Dis J. 1998 Nov;17(11):1001-7. doi: 10.1097/00006454-199811000-00007. Pediatr Infect Dis J. 1998. PMID: 9849982 Clinical Trial.
4,611 results